SCHEMBL27256993

SCHEMBL27256993

Cc1cc(COC(=O)C2CCCCC2C(=O)O)cc(I)c1O

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 2/20 0.42
CYP2C9 P11712 1/20 0.42
HIF1A Q16665 1/20 0.42
GAA P10253 1/20 0.40
ALDH1A1 P00352 3/20 0.38
LMNA P02545 1/20 0.36
RAB9A P51151 1/20 0.36
TP53 P04637 1/20 0.35
CYP3A4 P08684 1/20 0.35
GRM4 Q14833 1/20 0.35
SMN1; SMN2 Q16637 2/20 0.34
KDM4E B2RXH2 1/20 0.34
HTT P42858 1/20 0.34
ITGB3 P05106 1/20 0.34
ITGAV P06756 1/20 0.34
THRA P10827 1/20 0.34
THRB P10828 1/20 0.34
RXRA P19793 1/20 0.34
PPARG P37231 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27255526 0.95 CYP2C19 (0.46) CYP2C19CYP2C9HIF1AGAAALDH1A1
SCHEMBL27267749 0.79 ALDH1A1 (0.42) CYP2C19CYP2C9HIF1AALDH1A1LMNA
SCHEMBL7897964 0.74 RAB9A (0.54) GAAALDH1A1RAB9ASMN1; SMN2
SCHEMBL16117454 0.74 RAB9A (0.54) GAAALDH1A1RAB9ASMN1; SMN2
SCHEMBL10917139 0.74 RAB9A (0.54) GAAALDH1A1RAB9ASMN1; SMN2
SCHEMBL7897961 0.74 RAB9A (0.54) GAAALDH1A1RAB9ASMN1; SMN2
SCHEMBL16121069 0.74 RAB9A (0.54) GAAALDH1A1RAB9ASMN1; SMN2
SCHEMBL27255525 0.73 ALDH1A1 (0.43) CYP2C19CYP2C9HIF1AALDH1A1LMNA
SCHEMBL11767625 0.72 GAA (0.49) CYP2C19CYP2C9HIF1AGAAALDH1A1
SCHEMBL24325877 0.72 THRB (0.36) CYP2C9ALDH1A1LMNACYP3A4ITGB3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240210824-A1 CARBOXYLATE, CARBOXYLIC ACID GENERATOR, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2024-06-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240210824-A1 CARBOXYLATE, CARBOXYLIC ACID GENERATOR, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN SCO2, CBR1, OXGR1 CYP2C19 649/4885CYP2C9 327/4885HIF1A 763/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.